J 2024

Isoelectric focusing followed by affinity immunoblotting to detect monoclonal free light chains in monoclonal gammopathies: Comparison with immunofixation electrophoresis and free light chain ratio

ZEMAN, David, Martin ŠTORK, Lenka ŠVANCAROVÁ, Marek BORSKÝ, Michaela POSPÍŠILOVÁ et. al.

Basic information

Original name

Isoelectric focusing followed by affinity immunoblotting to detect monoclonal free light chains in monoclonal gammopathies: Comparison with immunofixation electrophoresis and free light chain ratio

Authors

ZEMAN, David (203 Czech Republic, belonging to the institution), Martin ŠTORK (203 Czech Republic, belonging to the institution), Lenka ŠVANCAROVÁ (203 Czech Republic, belonging to the institution), Marek BORSKÝ (203 Czech Republic, belonging to the institution), Michaela POSPÍŠILOVÁ (203 Czech Republic, belonging to the institution), Zdeněk ADAM (203 Czech Republic, belonging to the institution), Miroslava BEŇOVSKÁ (203 Czech Republic, belonging to the institution) and Luděk POUR (203 Czech Republic, belonging to the institution)

Edition

Annals of Clinical Biochemistry, THOUSAND OAKS, SAGE PUBLICATIONS INC, 2024, 0004-5632

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

20602 Medical laboratory technology ;

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 2.200 in 2022

Organization unit

Faculty of Medicine

UT WoS

001158687400001

Keywords in English

Isoelectric focusing; immunoblotting; immunofixation; free light chains; AL amyloidosis; multiple myeloma; minimal residual disease

Tags

International impact, Reviewed
Změněno: 5/11/2024 15:00, Mgr. Tereza Miškechová

Abstract

V originále

Background: Isoelectric focusing (IEF) is a method with an exquisite resolution, and coupled with affinity immunoblotting (AIB), it can provide superior sensitivity to detect monoclonal free light chains (FLC). Methods: We tested the hypothesis that IEF/AIB is more sensitive and specific for monoclonal FLC detection in serum and urine samples than conventional methods, that is, electrophoresis (ELP), immunofixation (IF) and serum FLC ratio assessment. Investigation included 107 samples of 68 patients, among which 21 multiple myeloma patients were recently tested for minimal residual disease and 18 patients with AL amyloidosis. Results: Monoclonal FLC were detected by IEF/AIB in 37% of serum samples negative for monoclonal FLC on ELP/IF. As for urine samples, significant advantage of the IEF/AIB over ELP/IF was not demonstrated. Considering both serum and urine results, IEF/AIB definitely revealed monoclonal FLC in 20/83 (24%) of ELP/IF-negative samples. FLC ratio was abnormally high (>1.65) in all 11 patients definitely positive for monoclonal FLC kappa by IEF/AIB but also in 16/47 (34%) IEF/AIB-negative samples. Abnormally low values (<0.26) were found only in 10/28 samples (36%) positive for monoclonal FLC lambda. Appropriate use of renal FLC ratio reference range reduced the number of presumably false positives (6/47, i.e. 13%) but not false negatives (17/28, i.e. 61%). Conclusions: The IEF/AIB method is more sensitive than IF and might be used in patients with negative IF results before deciding whether to proceed to minimal residual disease testing.